Phospho-Met (Tyr1234/1235) Sandwich ELISA Kit - CD BioSciences

service-banner

Phospho-Met (Tyr1234/1235) Sandwich ELISA Kit

Phospho-Met (Tyr1234/1235) Sandwich ELISA Kit

SPK-00826

Size Price
1 X 96T Online Inquiry
5 X 96T Online Inquiry
10 X 96T Online Inquiry
More Options Online Inquiry
Target Information
Target Name Met
Gene Abbr. MET
Gene ID 4233
Full Name MET proto-oncogene, receptor tyrosine kinase
Alias AUTS9, DFNB97, HGFR, RCCP2, c-Met
Introduction Met, a high affinity tyrosine kinase receptor for hepatocyte growth factor (HGF, also known as scatter factor) is a disulfide-linked heterodimer made of 45 kDa α- and 145 kDa β-subunits. The α-subunit and the amino-terminal region of the β-subunit form the extracellular domain. The remainder of the β-chain spans the plasma membrane and contains a cytoplasmic region with tyrosine kinase activity. Interaction of Met with HGF results in autophosphorylation at multiple tyrosines, which recruit several downstream signaling components, including Gab1, c-Cbl, and PI3 kinase. These fundamental events are important for all of the biological functions involving Met kinase activity. The addition of a phosphate at cytoplasmic Tyr1003 is essential for Met protein ubiquitination and degradation. Phosphorylation at Tyr1234/1235 in the Met kinase domain is critical for kinase activation. Phosphorylation at Tyr1349 in the Met cytoplasmic domain provides a direct binding site for Gab1. Research studies have shown that altered Met levels and/or tyrosine kinase activities are found in several types of tumors, including renal, colon, and breast. Thus, investigators have concluded that Met is an attractive potential cancer therapeutic and diagnostic target.
Product Details
Measurement Sandwich
Usage
Application ELISA
Reactivity
Sensitivity This kit detects Met when tyrosine phosphorylated at Tyr1234/1235.

For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.